[go: up one dir, main page]

ZA200107291B - Use of xenon for treating neurointoxications. - Google Patents

Use of xenon for treating neurointoxications.

Info

Publication number
ZA200107291B
ZA200107291B ZA200107291A ZA200107291A ZA200107291B ZA 200107291 B ZA200107291 B ZA 200107291B ZA 200107291 A ZA200107291 A ZA 200107291A ZA 200107291 A ZA200107291 A ZA 200107291A ZA 200107291 B ZA200107291 B ZA 200107291B
Authority
ZA
South Africa
Prior art keywords
xenon
neurointoxications
treating
treating neurointoxications
Prior art date
Application number
ZA200107291A
Other languages
English (en)
Inventor
Christian Petzelt
Wolfgang J Kox
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7900688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200107291(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aga Ab filed Critical Aga Ab
Publication of ZA200107291B publication Critical patent/ZA200107291B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200107291A 1999-03-11 2001-09-03 Use of xenon for treating neurointoxications. ZA200107291B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19910986A DE19910986C2 (de) 1999-03-11 1999-03-11 Verwendung von Xenon bei der Behandlung von Neurointoxikationen

Publications (1)

Publication Number Publication Date
ZA200107291B true ZA200107291B (en) 2003-02-26

Family

ID=7900688

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107291A ZA200107291B (en) 1999-03-11 2001-09-03 Use of xenon for treating neurointoxications.

Country Status (29)

Country Link
US (3) US6559190B1 (xx)
EP (1) EP1158992B2 (xx)
JP (1) JP4954373B2 (xx)
KR (1) KR100674407B1 (xx)
CN (1) CN1170544C (xx)
AR (1) AR022886A1 (xx)
AT (1) ATE248599T1 (xx)
AU (1) AU757361B2 (xx)
BG (1) BG105889A (xx)
BR (1) BR0010456A (xx)
CA (1) CA2367136C (xx)
CZ (1) CZ302864B6 (xx)
DE (2) DE19910986C2 (xx)
DK (1) DK1158992T3 (xx)
EE (1) EE200100480A (xx)
ES (1) ES2206202T5 (xx)
HK (1) HK1048073B (xx)
HU (1) HUP0201393A3 (xx)
IL (2) IL145177A0 (xx)
MD (1) MD2935C2 (xx)
NO (1) NO20014379L (xx)
PL (1) PL202941B1 (xx)
PT (1) PT1158992E (xx)
RS (1) RS49756B (xx)
RU (1) RU2246949C2 (xx)
SI (1) SI1158992T1 (xx)
SK (1) SK285111B6 (xx)
WO (1) WO2000053192A1 (xx)
ZA (1) ZA200107291B (xx)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913677D0 (en) 1999-06-11 1999-08-11 Imperial College Formulation
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
US6653354B2 (en) 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
DE10045829A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Volatile Anästhesiemittel mit Xenon
DE10054563A1 (de) * 2000-11-03 2002-05-16 Messer Griesheim Gmbh Verfahren und Vorrichtung zur Betonherstellung
US20020102211A1 (en) * 2000-12-07 2002-08-01 Renshaw Perry F. Use of magnetic resonance imaging in diagnosis of membrane fluidity-related disorders
GB0210021D0 (en) * 2002-05-01 2002-06-12 Air Prod & Chem Ultrasonic gas analyser
GB0209998D0 (en) † 2002-05-01 2002-06-12 Protexeon Ltd Use
EP1515732B1 (de) * 2002-06-12 2009-01-14 Air Liquide Deutschland GmbH Cerebrale protektion mit einem xenonhaltigen gas
WO2004004782A1 (de) * 2002-07-05 2004-01-15 Messer Griesheim Gmbh Xenon enthaltendes adjuvans
GB0218153D0 (en) * 2002-08-05 2002-09-11 Ic Innovations Ltd An analgesic agent for newborn or retal subjects
US7337776B2 (en) 2002-08-20 2008-03-04 Aga Ab Methods for easing pain and anxiety from atrial or ventricular defibrillation
US7681572B2 (en) 2002-08-20 2010-03-23 Aga Ab Method and devices for administration of therapeutic gases
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
ES2298815T3 (es) * 2003-10-10 2008-05-16 Protexeon Limited Uso de xenon con hipotermia para tratar asfixia neonatal.
CA2542412A1 (en) * 2003-10-21 2005-05-06 Aga Ab Use of xenon for the prevention of programmed cell death
FR2863169B1 (fr) 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
EP1552840A1 (en) * 2004-01-07 2005-07-13 Aga Ab Use of a xenon/carbon monoxide mixture for the protection of cells
US7070005B2 (en) * 2004-02-10 2006-07-04 Planetair Turf Products, Llc Soil aerator assembly
ATE553757T1 (de) * 2004-08-02 2012-05-15 John W Olney Verhinderung von pathologischen anstiegen der nervenzellsuizidrate in unreifen nervensystemen
WO2007075100A1 (en) * 2005-12-27 2007-07-05 Zakrytoe Aktsionernoe Obshchestvo 'atom-Med Center' Method for treating drug dependence
EP1980260A1 (en) * 2007-04-10 2008-10-15 Nicholas Peter Franks Use of hyperbaric conditions to provide neuroprotection
CA2685446A1 (en) 2007-04-30 2008-11-06 Nnoxe Pharmaceutiques Inc. Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
ITMI20071031A1 (it) * 2007-05-22 2008-11-23 Acetilene & Deriv Ati Siad Spa Uso di xenon per la protezione di organi da danno ischemico
WO2010035074A1 (en) * 2008-09-25 2010-04-01 Nnoxe Pharmaceutiques Inc Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents
FR2952305B1 (fr) 2009-11-10 2012-04-27 Air Liquide Medicament inhalable a base de xenon pour traiter ou pour prevenir les dyskinesies
WO2011081612A1 (ru) * 2009-12-31 2011-07-07 Bondarenko Vitaliy Leonidovich Применение криптона или ксенона в качестве противовирусного средства
FR2956323B1 (fr) 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
FR2960779A1 (fr) 2010-06-08 2011-12-09 Air Liquide Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques
FR2964036B1 (fr) 2010-08-24 2013-04-12 Air Liquide Medicament gazeux inhalable a base de krypton pour le traitement des neuro-intoxications
WO2012109107A1 (en) 2011-02-07 2012-08-16 Rich Products Corporation Method for preserving cells and cell cultures
FR2975597B1 (fr) * 2011-05-24 2013-12-27 Air Liquide Utilisation de neon pour le traitement des neuro-intoxications, notamment des maladies enurodegeneratives et demyelinisantes
PT2760991T (pt) 2011-09-26 2018-02-05 Rich Tech Holding Company Llc Método para a conservação de tecido vivo
RU2489154C1 (ru) * 2012-05-31 2013-08-10 Сергей Александрович Наумов Способ лечения вирусных гепатитов
CN103565745A (zh) 2012-08-10 2014-02-12 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
FR2996458B1 (fr) * 2012-10-09 2015-02-27 Air Liquide Utilisation de xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996459B1 (fr) * 2012-10-09 2015-02-06 Air Liquide Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996457B1 (fr) 2012-10-09 2019-11-29 L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique
PT2931291T (pt) 2012-12-11 2021-12-03 Mclean Hospital Corp Tratamento com xénon como complemento da psicoterapia para perturbações psiquiátricas
WO2014145443A2 (en) 2013-03-15 2014-09-18 The Board Of Regents Of The University Of Texas System Liquids rich in noble gas and methods of their preparation and use
FR3007983B1 (fr) * 2013-07-08 2015-06-26 Air Liquide Association de xenon et d'un antagoniste des recepteurs nmda pour lutter contre une maladie neurodegenerative
FR3022456B1 (fr) * 2014-06-20 2016-07-15 Air Liquide Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central
FR3027226B1 (fr) * 2014-10-17 2017-12-08 L'air Liquide Sa Pour L'etude Et L'exploitation Des Procedes Georges Claude Medicament pour traiter une maladie liee a un dysfonctionnement de la transmission synaptique dopaminergique
JP6622822B2 (ja) * 2015-06-23 2019-12-18 ノビリス セラピューティクス インコーポレイテッド 希ガス組成物を用いた治療的な免疫調節
CN108367024A (zh) * 2015-11-09 2018-08-03 麦克莱恩医院 用于预防自杀、杀人和自伤行为的方法及组合物
US20170341980A1 (en) * 2016-05-31 2017-11-30 Noblis Therapeutics, Inc. Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity
US10485825B2 (en) * 2016-08-29 2019-11-26 Nobilis Therapeutics, Inc. Prevention of pregnancy complications by noble gas administration
EP3532073A4 (en) * 2016-10-31 2020-09-02 Nobilis Therapeutics, Inc. TREATMENT OF ANXIETY DISORDER AND INCREASED ANTI-ANXIETY INTERVENTIONS BY ADMINISTRATION OF MIXTURES CONTAINING A NOBLE GAS
CN107569509B (zh) * 2017-02-22 2018-09-21 滨州医学院 氙或氙气体混合物在制备治疗癫痫的制剂中的用途
CN108986622A (zh) * 2018-08-16 2018-12-11 广州迈普再生医学科技股份有限公司 一种颅内血肿微创穿刺清除术培训装置及其制备方法
RU2712804C1 (ru) * 2018-08-29 2020-01-31 Жовнерчук Инна Юрьевна Способ коррекции функционального состояния человека в замкнутом пространстве
RU2789964C1 (ru) * 2022-04-01 2023-02-14 Александр Юрьевич Верховский Способ улучшения состояния кожи и подкожных тканей

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
US5228434A (en) * 1991-07-16 1993-07-20 Praxair Technology, Inc. Mixture for anesthesia
US5357959A (en) * 1993-04-16 1994-10-25 Praxair Technology, Inc. Altered dipole moment magnetic resonance imaging method
RU2145606C1 (ru) * 1994-05-24 2000-02-20 Ф.Хоффманн-Ля Рош Аг Трициклические дикарбонильные производные и лекарственный препарат на их основе
RU2072241C1 (ru) * 1995-09-20 1997-01-27 Панина Елена Владимировна Способ формирования дыхательной газовой смеси и аппарат для его осуществления
US5846556A (en) * 1996-06-14 1998-12-08 Brooks; Bradley S. Inhalant for reducing stress and method of use
IT1286058B1 (it) * 1996-10-29 1998-07-07 Siad Societa Italiana Acetilen Procedimento e apparecchiatura per la purificazione e recupero dello xeno e altri gas nobili in sistemi anestetici
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist

Also Published As

Publication number Publication date
PT1158992E (pt) 2004-01-30
BG105889A (bg) 2002-04-30
DE19910986A1 (de) 2000-09-21
YU65401A (sh) 2004-07-15
HUP0201393A2 (en) 2002-09-28
HUP0201393A3 (en) 2002-10-28
IL145177A0 (en) 2002-06-30
MD2935B2 (en) 2005-12-31
CN1359296A (zh) 2002-07-17
US8143317B2 (en) 2012-03-27
US20030180375A1 (en) 2003-09-25
EE200100480A (et) 2002-12-16
SI1158992T1 (en) 2004-02-29
CA2367136A1 (en) 2000-09-14
ATE248599T1 (de) 2003-09-15
AU757361B2 (en) 2003-02-20
CN1170544C (zh) 2004-10-13
BR0010456A (pt) 2002-08-27
AU3287500A (en) 2000-09-28
JP2002538209A (ja) 2002-11-12
HK1048073A1 (en) 2003-03-21
AR022886A1 (es) 2002-09-04
US20070110821A1 (en) 2007-05-17
PL350618A1 (en) 2003-01-27
PL202941B1 (pl) 2009-08-31
EP1158992B2 (en) 2012-02-01
SK12792001A3 (sk) 2002-07-02
SK285111B6 (sk) 2006-06-01
KR20010108338A (ko) 2001-12-07
ES2206202T5 (es) 2012-05-22
EP1158992A1 (en) 2001-12-05
DE60004974T3 (de) 2012-06-28
WO2000053192A1 (en) 2000-09-14
HK1048073B (zh) 2005-06-03
IL145177A (en) 2006-10-31
EP1158992B1 (en) 2003-09-03
DE19910986C2 (de) 2001-06-07
DK1158992T3 (da) 2003-12-29
ES2206202T3 (es) 2004-05-16
DE60004974D1 (de) 2003-10-09
CA2367136C (en) 2008-05-13
US6559190B1 (en) 2003-05-06
MD20010349A (en) 2002-02-28
KR100674407B1 (ko) 2007-01-26
MD2935C2 (ro) 2006-08-31
JP4954373B2 (ja) 2012-06-13
RS49756B (sr) 2008-04-04
CZ20013234A3 (cs) 2002-06-12
DE60004974T2 (de) 2004-07-22
NO20014379D0 (no) 2001-09-10
RU2246949C2 (ru) 2005-02-27
NO20014379L (no) 2001-11-07
CZ302864B6 (cs) 2011-12-21

Similar Documents

Publication Publication Date Title
ZA200107291B (en) Use of xenon for treating neurointoxications.
ZA200202449B (en) Use of retigabin for treating neuropathic pain.
MXPA02002646A (es) Aparato para tratamiento de agua.
ZA200108446B (en) Novel method of treatment.
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB9925136D0 (en) Novel treatment
EG24462A (en) Compounds for treating fundic disaccomodation
AU4498201A (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
IL144186A0 (en) Novel treatment
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
SG89379A1 (en) Treatment apparatus
ZA200203166B (en) Treatment of cancer.
IL151871A0 (en) Restenosis treatment
GB0031321D0 (en) Treatment
AU1036801A (en) Agent for treating cephalic pain
HUP0203741A3 (en) Treatment of osteoporosis
GB9908993D0 (en) Treatment
NZ514013A (en) Treatment of hiatial hernia
ZA200002170B (en) Treatment of acarids.
GB9923111D0 (en) Effluent treatment
GB9920787D0 (en) Novel treatment
GB9916655D0 (en) Novel treatment
GB9909650D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment
GB9923343D0 (en) Treatment system